Results 31 to 40 of about 231,281 (308)

Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies

Medicine in Drug Discovery, 2020
The COVID-19 pandemic, after it was reported in December 2019, is a highly contagious and now spreading to over 190 countries, causing a severe public health burden.
Jiayu Liao, George Way, Vipul Madahar
doaj   +1 more source

Repurposing Existing Drugs for the Treatment of COVID-19

Annals of the American Thoracic Society, 2020
Abstract The rapid global spread and significant mortality associated with the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection has spurred an urgent race to find effective treatments.
Hugo Farne, Kartik Kumar, Andrew I. Ritchie, Lydia J. Finney, Sebastian L. Johnston, Aran Singanayagam   +5 more
openaire   +3 more sources

Psychopharmacological treatment in COVID-19 pandemic [PDF]

Klinik Psikiyatri Dergisi, 2020
The COVID-19 infection is still active both worldwide and in our country. Hereafter, it is going to have marked effects on clinical psychiatric practice. So, it is very important to consider the interactions of psychotropic drugs used in the COVID-19
Safiye Zeynep Tatlı, Gülsüm Çakar, Burçin Çolak, Erguvan Tuğba Özel Kızıl   +3 more
doaj   +1 more source

Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses for COVID-19

, 2021
Publisher Copyright: © 2021 Elsevier Inc. All rights reserved.Peer reviewedThe current COVID-19 pandemic has spread rapidly worldwide and has challenged fragile health care systems, vulnerable socioeconomic conditions, and population risk factors, and ...
Brenda Rojas Román, Del-Aguila-Arcentales, Shyla, Aldo Alvarez-Risco, Christian R. Mejia, Alvarez-Risco, Aldo, Palmer J. Hernández-Yépez, Yáñez, Jaime A., Chung, Sun Ah, Román, Brenda Rojas, Inga-Berrospi, Fiorella, Sun Ah Chung, Franko O. Garcia-Solorzano, Hernández-Yépez, Palmer J., Mejia, Christian R., Garcia-Solorzano, Franko O., Shyla Del-Aguila-Arcentales, Jaime A. Yáñez, Fiorella Inga-Berrospi   +17 more
core   +1 more source

A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy

Pharmaceutical Sciences and Research, 2020
Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can be aggravated by comorbid diseases.
Ana Khusnul Faizah, Nani Wijayanti Dyah Nurrahman, Oki Nugraha Putra   +2 more
doaj   +1 more source

Different COVID-19 treatments’ impact on hospital length of stay

European Journal of Medical Research, 2023
Importance COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients ...
Satori Iwamoto, Bahaar Kaur Muhar, Hao Chen, Harrison Chu, Mason Johnstone, Ashwin Sidhu, Hillary Chu, Joseph Fischer, Gary Chu   +8 more
doaj   +1 more source

Natural products as environmentally safe and green approach to combat Covid-19

Current Research in Green and Sustainable Chemistry, 2021
The Covid-19 pandemic is a major catastrophe in recent times that has taken a toll over the global scale in terms of the casualties, economic impact, and human beings' lifestyle.
Dheeraj Singh Chauhan, Shailendra Yadav, M.A. Quraishi   +2 more
doaj   +1 more source

Teicoplanin: an alternative drug for the treatment of COVID-19?

International Journal of Antimicrobial Agents, 2020
In December 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged from China causing pneumonia outbreaks, first in the Wuhan region of China and then spread worldwide because of its probable high transmission efficiency.
Baron, Sophie Alexandra, Devaux, Christian, Colson, Philippe, Raoult, Didier, Rolain, Jean-Marc   +4 more
openaire   +3 more sources

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study [PDF]

, 2020
Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in ...
Lecumberri, Jose Javier Napal, Garcia, Marcos Guzmán, Rodríguez, Begoña Cortés, López-Carmona, María D, Fuentes-Jiménez, Francisco, Jorge Ripper, Carlos, Fernández Sola, Joaquim, Napal Lecumberri, José Javier, SEMI-COVID-19 Network, Ramos-Rincón, José Manuel, Guzmán García, Marcos, Rubio-Rivas, Manuel, Martínez, Francisco Amorós, Pérez-Martínez, Pablo, Cosío, Sara Fuente, Amorós Martínez, Francisco, Gómez-Huelgas, Ricardo, López-Carmona, María D., Ena, Javier, Ayala-Gutiérrez, M. Mar, Canteli, Susana Plaza, Ayala-Gutiérrez, M. Mar., Madrazo, Manel, Cortés Rodríguez, Begoña, Pérez, Carmen Mella, Rubio Rivas, Manuel, Acedo, Iris El Attar, Ayala-Gutiérrez, M Mar, Vicente Montes, Beatriz, Alonso Muñoz, Jaime, Fuentes-Jiménez, Francisco J., Pérez-Belmonte, Luis M., González Ferrer, Ruth, Ferrer, Ruth Gonzalez, Torres-Peña, José David, Sola, Joaquim Fernández, Pérez Martínez, Pablo, Torres‑Peña, J.D., Plaza Canteli, Susana, Pérez-Belmonte, Luis M, Montes, Beatriz Vicente, Ripper, Carlos Jorge, Fuente Cosío, Sara, El Attar Acedo, Iris, Huerta, Lucía Jorge, Muñoz, Jaime Alonso, Mella Perez, Carmen, Jorge Huerta, Lucía   +47 more
core   +1 more source

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment [PDF]

Frontiers in Immunology, 2021
The magnitude of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prompted the repurposing of several drugs to quickly stop the morbidity, mortality, and spread of this new disease.
openaire   +4 more sources